EW Q4 2018 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$978M+10.0% YoY

Gross Profit

$742M75.8% margin

Operating Income

$290M29.7% margin

Net Income

$7M0.7% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$293M

Free Cash Flow

$232M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$5.3B

Total Liabilities

$2.2B

Stockholders' Equity

$3.1B

Cash & Equivalents

$714M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$978M	$889M	+10.0%
Gross Profit	$742M	$653M	+13.5%
Operating Income	$290M	$241M	+20.2%
Net Income	$7M	$36M	-80.4%

Revenue Segments

Transcatheter Heart Valves

$592M61%

Surgical Heart Valve Therapy

$207M21%

Critical Care

$178M18%

Geographic Segments

UNITED STATES

$545M56%

Europe

$226M23%

JAPAN

$107M11%

Rest of World

$100M10%